Loading company…
Tempero Bio develops treatments for substance use disorders.
Tempero Bio is a clinical-stage biopharmaceutical company developing TMP-301 for alcohol and cocaine use disorders and other potential indications. Its research focuses on therapies for people with substance use disorders. Founded in 2020, the company is based in Oakland, US. It raised USD 70.000 mn in Series B funding in March 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in